KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Preferred Shares: 2009-2011

Historic Preferred Shares for Jazz Pharmaceuticals (JAZZ) over the last 2 years, with Mar 2011 value amounting to $4,000.

  • Jazz Pharmaceuticals' Preferred Shares rose 33.33% to $4,000 in Q1 2011 from the same period last year, while for Mar 2011 it was $4,000, marking a year-over-year increase of 33.33%. This contributed to the annual value of $4,000 for FY2010, which is 33.33% up from last year.
  • As of Q1 2011, Jazz Pharmaceuticals' Preferred Shares stood at $4,000, which was down 0.00% from $4,000 recorded in Q4 2010.
  • Over the past 5 years, Jazz Pharmaceuticals' Preferred Shares peaked at $4,000 during Q2 2010, and registered a low of $3,000 during Q1 2009.
  • Over the past 3 years, Jazz Pharmaceuticals' median Preferred Shares value was $3,000 (recorded in 2010), while the average stood at $3,444.
  • Data for Jazz Pharmaceuticals' Preferred Shares shows a peak YoY skyrocketed of 33.33% (in 2010) over the last 5 years.
  • Over the past 3 years, Jazz Pharmaceuticals' Preferred Shares (Quarterly) stood at $3,000 in 2009, then spiked by 33.33% to $4,000 in 2010, then spiked by 33.33% to $4,000 in 2011.
  • Its Preferred Shares was $4,000 in Q1 2011, compared to $4,000 in Q4 2010 and $4,000 in Q3 2010.